We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.72B
AUM Growth
+$141M
Cap. Flow
+$95.8M
Cap. Flow %
5.57%
Top 10 Hldgs %
21.85%
Holding
2,270
New
651
Increased
413
Reduced
537
Closed
573

Top Buys

Rank Stock Value
1
CA
CA, Inc.
CA
+$32.4M
2
DELL icon
Dell
DELL
+$32.1M
3
DNB
Dun & Bradstreet
DNB
+$28.2M
4
ANDV
Andeavor
ANDV
+$20.3M
5
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$17.8M

Top Sells

Rank Stock Value
1
XL
XL Group Ltd.
XL
+$38M
2
NXPI icon
NXP Semiconductors
NXPI
+$20.6M
3
VR
Validus Hold Ltd
VR
+$20.3M
4
PAY
Verifone Systems Inc
PAY
+$15.4M
5
RSPP
RSP Permian, Inc.
RSPP
+$13.7M

Sector Composition

Rank Sector Weight
1 Technology 14.61%
2 Healthcare 9.84%
3 Financials 8.44%
4 Communication Services 8.41%
5 Energy 5.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
X
426
PUT
DELISTED
US Steel
X
$735K 0.04%
24,100
– –
CLB icon
427
Core Laboratories
CLB
$521M
$731K 0.04%
6,308
-223
-3% -$25.2K
SGMO
428
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$725K 0.04%
42,759
– –
NVDA icon
429
NVIDIA
NVDA
$5.42T
$721K 0.04%
102,560
-1,309,720
-93% -$8.52M
BPMC
430
DELISTED
Blueprint Medicines
BPMC
$716K 0.04%
9,172
+5,593
+156% +$389K
ADAP
431
DELISTED
Adaptimmune Therapeutics
ADAP
$715K 0.04%
52,759
-139
-0.3% -$1.46K
VRE
432
DELISTED
Veris Residential
VRE
$712K 0.04%
33,504
+4,069
+14% +$82.9K
OI icon
433
PUT
O-I Glass
OI
$1.08B
$705K 0.04%
+37,500
New +$674K
CC icon
434
PUT
Chemours
CC
$2.37B
$702K 0.04%
+17,800
New +$779K
CMBT
435
CMB.TECH NV
CMBT
$4.73B
$702K 0.04%
80,645
-64,085
-44% -$545K
MPT
436
Medical Properties Trust
MPT
$2.81B
$695K 0.04%
+46,590
New +$679K
BBBY
437
DELISTED
Bed Bath & Beyond Inc
BBBY
$693K 0.04%
46,170
+43,591
+1,690% +$816K
BMRN icon
438
BioMarin Pharmaceuticals
BMRN
$12.4B
$692K 0.04%
7,137
+2,758
+63% +$275K
OKTA icon
439
Okta
OKTA
$25.8B
$692K 0.04%
9,838
-11,196
-53% -$667K
JAG
440
CALL
DELISTED
Jagged Peak Energy Inc.
JAG
$692K 0.04%
+50,000
New +$677K
GBNK
441
DELISTED
Guaranty Bancorp
GBNK
$690K 0.04%
+23,229
New +$710K
HCA icon
442
HCA Healthcare
HCA
$89.5B
$688K 0.04%
4,943
-3,062
-38% -$381K
TECX
443
Tectonic Therapeutic
TECX
$606M
$674K 0.04%
+1,083
New +$480K
STNG icon
444
Scorpio Tankers
STNG
$3.81B
$673K 0.04%
33,459
+33,168
+11,398% +$720K
LPNT
445
DELISTED
LifePoint Health, Inc.
LPNT
$672K 0.04%
10,428
+8,545
+454% +$521K
STIM icon
446
Neuronetics
STIM
$166M
$670K 0.04%
20,912
+4,912
+31% +$149K
SJM icon
447
PUT
J.M. Smucker
SJM
$12.8B
$667K 0.04%
6,500
+400
+7% +$43.7K
SWK icon
448
Stanley Black & Decker
SWK
$15.7B
$662K 0.04%
+4,519
New +$643K
VTRS icon
449
Viatris
VTRS
$18.9B
$661K 0.04%
+18,060
New +$678K
HUYA
450
Huya Inc
HUYA
$558M
$660K 0.04%
+28,000
New +$834K
16 17
18
19 20

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Prelude Capital Management held 2,270 positions worth $1.72B, up 8.9% from $1.58B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Prelude Capital Management deployed $95.8M of net new capital in Q3 2018, opening 651 new positions and adding to 413 existing holdings. Its largest new stake was SodaStream International Ltd: 71,388 shares worth $10.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NXP Semiconductors, an estimated $20.6M trimmed.

  • Prelude Capital Management's largest Q3 2018 buy was SodaStream International Ltd: 71,388 shares worth $10.2M.
  • Prelude Capital Management added most to CA, Inc. in Q3 2018, an estimated $32.4M increase.
  • Prelude Capital Management's biggest Q3 2018 reduction was NXP Semiconductors, cutting an estimated $20.6M.
  • Prelude Capital Management fully exited XL Group Ltd. in Q3 2018, selling an estimated $38M.
  • Prelude Capital Management's ten largest holdings make up 22% of its $1.72B portfolio in Q3 2018.
  • Prelude Capital Management opened 651 new positions and closed 573 in Q3 2018.
  • Prelude Capital Management's portfolio value rose 8.9% quarter-over-quarter to $1.72B.

Based on Prelude Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.